NCT04172493 is a NA clinical trial of Hyperspectral Endoscopy (HySE) in Patient, sponsored by OHSU Knight Cancer Institute.

Who is sponsoring NCT04172493?

NCT04172493 is sponsored by OHSU Knight Cancer Institute.

What drugs are being tested in NCT04172493?

Interventions in NCT04172493: Hyperspectral Endoscopy (HySE), White Light Endoscopy (WLE).

Is NCT04172493 still recruiting?

NCT04172493 is currently completed. Last updated 8 May 2020.

Last reviewed 2020-05-08 · How we verify

NCT04172493

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hyperspectral Endoscopy Imaging for the Early Detection of Precancerous Lesions in Average Risk Patients

Completed NA Last updated 8 May 2020

What this trial tests

NA trial testing Hyperspectral Endoscopy (HySE) in Patient in 13 participants. Completed in 27 January 2020.

Timeline

26 August 2019

Primary endpoint
27 January 2020

27 January 2020

Quick facts

Lead sponsor	OHSU Knight Cancer Institute
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	13
Start date	26 August 2019
Primary completion	27 January 2020
Estimated completion	27 January 2020
Sites	1 location across United States

Drugs / interventions tested

Hyperspectral Endoscopy (HySE)
White Light Endoscopy (WLE)

Conditions studied

Patient — all drugs for Patient →

Sponsor

OHSU Knight Cancer Institute

Who can join

18 and older, any sex, with Patient. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial studies whether hyperspectral endoscopy improves visualization of abnormal tissue in average risk patients during standard-of-care colonoscopies. Hyperspectral endoscopy is an emerging technique that has the potential to enable the signals from blood to be resolved from tissue-specific signals. Image-enhanced endoscopy may improve visualization of abnormal colonic tissue when compared to the standard-of-care high-definition white light endoscopy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Targeted multispectral filter array design for the optimization of endoscopic cancer detection in the gastrointestinal tract.
Taylor-Williams M, Tao R, Sawyer TW, Waterhouse DJ, et al · · 2024 · cited 1× · PMID 38560531 · DOI 10.1117/1.jbo.29.3.036005

Verify or expand the search:

Other recruiting trials for Patient

Currently open trials in the same condition.

NCT07465848 — Prospective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer Diagnosis · NA · recruiting
NCT07531004 — Effect of Progressive Relaxation Exercises on Sleep, Anxiety, and Body Image in Burn Patients · NA · active not recruiting
NCT06525181 — AI as an Aid for Weekly Symptom Intake in Radiotherapy · NA · recruiting
NCT06369103 — The Sedative Effects of Dexmedetomidine VS Propofol During Peribulbar Anesthesia in Patients Undergoing Vitrectomy Surge · Phase 4 · recruiting
NCT05288140 — Efficacy of the Use of Diaries in Intensive Care Units · NA · recruiting

Other OHSU Knight Cancer Institute trials

Trials by the same sponsor.

NCT05453851 — A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatme · Phase 1, PHASE2 · not yet recruiting
NCT07511504 — Y-90 Radioembolization, Durvalumab, Tremelimumab, and Zanzalintinib for the Treatment of Unresectable and Locally-Advanc · Phase 2 · not yet recruiting
NCT07434128 — Mammogram Pretreatment With Ulipristal Acetate · Phase 2 · not yet recruiting
NCT07504835 — GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer · NA · not yet recruiting
NCT07498517 — Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04172493 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by OHSU Knight Cancer Institute
Last refreshed: 8 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04172493.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing